Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5908 | 1489 | 59.3 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
475 | 15008 | ALLOPREGNANOLONE//PREMATURE EJACULATION//NEUROSTEROID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUROENDOCRINE BIOCHEM | Address | 17 | 43% | 2% | 30 |
2 | NON FEMINIZING ESTROGENS | Author keyword | 9 | 83% | 0% | 5 |
3 | HUMAN BIOCHEM | Address | 7 | 20% | 2% | 30 |
4 | EMERGENCY MED BRAIN | Address | 6 | 80% | 0% | 4 |
5 | ANAT ZELLBIOL ABT | Address | 6 | 35% | 1% | 13 |
6 | ESTROGEN ESTRADIOL | Author keyword | 4 | 67% | 0% | 4 |
7 | BAM INT UNIT | Address | 4 | 75% | 0% | 3 |
8 | CLIN EXPT MED CLIN CHEM | Address | 4 | 75% | 0% | 3 |
9 | WOMENS HLTH NEUROSCI PROGRAM | Address | 4 | 44% | 0% | 7 |
10 | CLIN EXPT MED NEUROSURG | Address | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NON FEMINIZING ESTROGENS | 9 | 83% | 0% | 5 | Search NON+FEMINIZING+ESTROGENS | Search NON+FEMINIZING+ESTROGENS |
2 | ESTROGEN ESTRADIOL | 4 | 67% | 0% | 4 | Search ESTROGEN+ESTRADIOL | Search ESTROGEN+ESTRADIOL |
3 | SILASTIC CAPSULE | 3 | 100% | 0% | 3 | Search SILASTIC+CAPSULE | Search SILASTIC+CAPSULE |
4 | 17 ALPHA ESTRADIOL | 3 | 24% | 1% | 10 | Search 17+ALPHA+ESTRADIOL | Search 17+ALPHA+ESTRADIOL |
5 | ESTRATRIENES | 2 | 67% | 0% | 2 | Search ESTRATRIENES | Search ESTRATRIENES |
6 | FUNCTIONAL REPAIR | 2 | 67% | 0% | 2 | Search FUNCTIONAL+REPAIR | Search FUNCTIONAL+REPAIR |
7 | SILASTIC CAPSULES | 2 | 67% | 0% | 2 | Search SILASTIC+CAPSULES | Search SILASTIC+CAPSULES |
8 | SLOW RELEASE PELLET | 2 | 67% | 0% | 2 | Search SLOW+RELEASE+PELLET | Search SLOW+RELEASE+PELLET |
9 | SLOW RELEASE PELLETS | 2 | 67% | 0% | 2 | Search SLOW+RELEASE+PELLETS | Search SLOW+RELEASE+PELLETS |
10 | SN56 CELL LINE | 2 | 67% | 0% | 2 | Search SN56+CELL+LINE | Search SN56+CELL+LINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ESTRADIOL PROTECTS | 145 | 75% | 7% | 106 |
2 | ESTRADIOL MEDIATED PROTECTION | 36 | 77% | 2% | 24 |
3 | SENESCENT FEMALE RATS | 24 | 82% | 1% | 14 |
4 | AMYLOID 25 35 INDUCED TOXICITY | 21 | 73% | 1% | 16 |
5 | EXPERIMENTAL STROKE | 16 | 15% | 7% | 98 |
6 | PRIMARY CORTICAL NEURONS | 13 | 30% | 2% | 37 |
7 | ESTROGEN MEDIATED NEUROPROTECTION | 13 | 71% | 1% | 10 |
8 | PENETRATING BRAIN INJURY | 12 | 63% | 1% | 12 |
9 | GONADAL HORMONE REGULATION | 12 | 54% | 1% | 15 |
10 | CORTICAL EXPLANT CULTURES | 11 | 78% | 0% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Selective estrogen receptor modulators (SERMs) enhance neurogenesis and spine density following focal cerebral ischemia | 2015 | 4 | 46 | 41% |
The neuroprotective actions of oestradiol and oestrogen receptors | 2015 | 3 | 175 | 53% |
Progesterone's role in neuroprotection, a review of the evidence | 2013 | 20 | 205 | 61% |
Neuroprotective actions of estradiol revisited | 2011 | 31 | 71 | 61% |
Estrogens and neuroprotection | 2002 | 126 | 5 | 100% |
Progesterone exerts neuroprotective effects after brain injury | 2008 | 122 | 127 | 45% |
Progesterone for the treatment of experimental brain injury; a systematic review | 2008 | 82 | 57 | 58% |
Progesterone as a neuroprotective factor in traumatic and ischemic brain injury | 2009 | 85 | 101 | 44% |
Neuroprotective effects of estrogens following ischemic stroke | 2009 | 76 | 108 | 47% |
Neuroprotection of sex steroids | 2010 | 36 | 97 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROENDOCRINE BIOCHEM | 17 | 43% | 2.0% | 30 |
2 | HUMAN BIOCHEM | 7 | 20% | 2.0% | 30 |
3 | EMERGENCY MED BRAIN | 6 | 80% | 0.3% | 4 |
4 | ANAT ZELLBIOL ABT | 6 | 35% | 0.9% | 13 |
5 | BAM INT UNIT | 4 | 75% | 0.2% | 3 |
6 | CLIN EXPT MED CLIN CHEM | 4 | 75% | 0.2% | 3 |
7 | WOMENS HLTH NEUROSCI PROGRAM | 4 | 44% | 0.5% | 7 |
8 | CLIN EXPT MED NEUROSURG | 3 | 100% | 0.2% | 3 |
9 | NEUROBIOL AGING | 3 | 14% | 1.2% | 18 |
10 | MILAN MOL PHARMACOL | 3 | 60% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000253927 | BIOPHYS LIFE SCI//PROJECT SPECIAL COORDINATE FUNDS PROMOTING SCI//SPINE SYNAPSE DENSITY |
2 | 0.0000165781 | GPR30//GPER//PELP1 |
3 | 0.0000117986 | SUBPROGRAM BIOPSYCHOL//NIGROSTRIATAL//BIOPSYCHOL BEHAV NEUROSCI PHD SUBPROGRAM |
4 | 0.0000108887 | UCLA MULTIPLE SCLEROSIS PROGRAM//MULTIPLE SCLEROSIS PROGRAM//POSTPARTUM ACTIVATION |
5 | 0.0000085863 | ALLOPREGNANOLONE//NEUROSTEROID//NEUROSTEROIDS |
6 | 0.0000083435 | MEMBRANE PROGESTIN RECEPTOR//PGRMC1//PGRMC2 |
7 | 0.0000080972 | WOBBLER MOUSE//T 588//WOBBLER MICE |
8 | 0.0000067808 | LORDOSIS//SEXUAL DIFFERENTIATION//PREOPTIC AREA |
9 | 0.0000066393 | ASCORBYL RADICALS//UNIDAD INVEST GERONTOL//FISIOPATOL GENET MOL HUMANA |
10 | 0.0000055145 | SPINAL NUCLEUS OF THE BULBOCAVERNOSUS//BULBOCAVERNOSUS//BHRP |